|
22 Feb 2011 |
Transgene Announces the Termination by Roche of the License Agreement on TG4001/RG3484 for the Treatment of Diseases Caused by the Human Papilloma Virus (''HPV'')
|
|
21 Feb 2011 |
Intercell announces start of pivotal Phase II/III study in India for vaccine to protect children from Japanese Encephalitis
|
|
18 Feb 2011 |
Clinical Responses Demonstrated in Metastatic Castrate Resistant Prostate Cancer Patients Treated With BPX-101 Cancer Vaccine
|
|
18 Feb 2011 |
NOVAVAX Presents Final Results from H1N1 Influenza Vaccine Trial at World Health Organization Meeting
|
|
18 Feb 2011 |
Prima BioMed Receives Regulatory Scientific Advice on CVac Phase III Trial
|
|
16 Feb 2011 |
New Pneumococcal Vaccine Approach Successful in Early Tests
|
|
14 Feb 2011 |
Diamyd Medical: Last Patient Completes the EU Phase III Study of Diamyd® Antigen Based Therapy for Type 1 Diabetes
|
|
09 Feb 2011 |
Liquidia Technologies Announces Collaboration with the Path Malaria Vaccine Initiative
|
|
08 Feb 2011 |
Medicago receives FDA regulatory clearance to initiate U.S. clinical trial for a new influenza vaccine candidate
|
|
07 Feb 2011 |
Inovio Pharmaceuticals Unveils Needle-free, Contactless Electroporation Technology for DNA Vaccine Delivery
|
|
03 Feb 2011 |
New England Journal of Medicine Publishes Efficacy and Safety Data for GARDASIL in Males
|
|
02 Feb 2011 |
Inovio Pharmaceuticals' Dual-Antigen SynCon DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial
|
|
02 Feb 2011 |
ImmunoCellular Therapeutics Announces First Patient Enrolled In Its Phase II Trial of ICT-107
|
|
02 Feb 2011 |
European Commission approves nasal spray vaccine FLUENZ for the prevention of seasonal influenza in children
|
|
01 Feb 2011 |
Bavarian Nordic Completes Smallpox Vaccine Phase 2 Trial in Vulnerable Population
|
|
01 Feb 2011 |
Circassia's ToleroMune(R) T-cell Vaccine Achieves Significant Reduction in Allergy Symptoms in Key Phase II Clinical Study
|
|
31 Jan 2011 |
Sinovac Biotech Files Clinical Trial Applications with SFDA for its Proprietary Pneumococcal Polysaccharides Vaccines (PPV)
|
|
31 Jan 2011 |
FDA approves the Novartis quadrivalent meningococcal conjugate vaccine, Menveo, for use in children from 2 years of age
|
|
31 Jan 2011 |
University of Southampton and Inovio Pharmaceuticals Initiate Phase 2 Clinical Study to Evaluate Leukemia DNA Vaccine Using Electroporation Delivery Technology
|
|
25 Jan 2011 |
BioSante Announces FDA Orphan Drug Designation for its Melanoma Cancer Vaccine
|
|
25 Jan 2011 |
Generex to Increase Patient Enrollment of its Phase II Breast Cancer Vaccine Study
|
|
25 Jan 2011 |
GenVec and U.S. Naval Medical Research Center to Collaborate on Vaccine for Dengue Fever
|
|
24 Jan 2011 |
Northwest Biotherapeutics Resuming Enrollment In Promising 240-Patient Clinical Trial of DCVax for Brain Cancer
|
|
21 Jan 2011 |
Joint development of therapeutic cancer vaccine WT4869
|
|
14 Jan 2011 |
Independent Data Safety Monitoring Board Gives “Go-Ahead” to Complete Dosing in First Leg of Advaxis’ Phase II Cervical Dysplasia Trial
|
